Dynamic Profiling in Patients with Metastatic Clear Cell Renal Cell Carcinoma (mrcc) Undergoing First-Line Treatment with Cabozantinib: A Sub-Exploratory Analysis from CABOPRE Trial.
Journal of Clinical Oncology（2024）
Key words
3282-206-3896-5046,3282-270-9760,283-2494-9200,171,171,38092-21981
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined